THE NATIONAL IMPACT OF RITODRINE HYDROCHLORIDE FOR INHIBITION OF PRETERM LABOR
- 1 July 1990
- journal article
- research article
- Vol. 76 (1) , 12-15
Abstract
Ritodrine hydrochloride is a .beta.2-receptor agonist that relaxes uterine smooth muscle. It was developed specifically for treatment of preterm labor and was approved for this indication in 1980 by the Food and Drug Administration. Estimates of ritodrine usage in the United States were calculated based upon annual sales, and these were examined in relation to the incidence of births in 500-g weight categories less than 2500 g. We estimate that more than 100,000 women with preterm labor are treated with ritodrine annually, but this has had minimal if any impact on the incidence of low birth weight in this country.This publication has 10 references indexed in Scilit:
- Beta‐mimetics in preterm labour: an overview of the randomized controlled trialsBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOURThe Lancet, 1986
- Ritodrine in the Treatment of Preterm LaborObstetrics & Gynecology, 1986
- β-Adrenergic receptors in human myometrium during pregnancy: Changes in the number of receptors after β-mimetic treatmentAmerican Journal of Obstetrics and Gynecology, 1985
- EFFECT OF TOCOLYSIS ON INCIDENCE OF LOW-BIRTH-WEIGHT1983
- Cardiovascular complications associated with terbutaline treatment for preterm laborAmerican Journal of Obstetrics and Gynecology, 1981
- Consequences of hormone-induced desensitization of adenylate cyclase in intact cellsBiochemical Journal, 1980
- RITODRINE HYDROCHLORIDE - A BETA-MIMETIC AGENT FOR USE IN PRETERM LABOR .1. PHARMACOLOGY, CLINICAL HISTORY, ADMINISTRATION, SIDE-EFFECTS, AND SAFETY1980
- RITODRINE HYDROCHLORIDE - A BETA-MIMETIC AGENT FOR USE IN PRETERM LABOR .2. EVIDENCE OF EFFICACY1980
- TREATMENT OF PREMATURE LABOR WITH RITODRINE - RANDOMIZED CONTROLLED-STUDY1979